Your academic institution may have purchased access to content. Find your institution below and we'll take you to your institution's login page
Login here to access an Administrator account for an institution, a personal subscription or to manage your alerts.
Receive monthly Table of Contents alerts from The Bone & Joint Journal
Comprehensive article alerts can be set up and managed through your account settings
View my account settings
1. Reports of the lipaemia-clearing effect of heparin suggested that this drug might be of therapeutic value in fat embolism.
2. In an experimental trial with rats, heparin was found both to accelerate death and to increase the number of deaths after fat embolism.
3. It is accordingly concluded that a clinical trial of heparin in human fat embolism would not be warranted.
Downloaded 162 times
